Sort by
Refine Your Search
-
@ucl.ac.uk) or Prof Peter Lee (peter.lee@ucl.ac.uk). For application process queries, contact Ruikang Xue (ruikang.xue@ucl.ac.uk). About you You will have a PhD in a relevant discipline (e.g. computational
-
generate the world’s highest resolution imaging of ex vivo human biomechanics? A new Research Fellow position is available to join the UCL team working with the European Synchrotron (ESRF) doing this work
-
biology methods, and neurological disease modelling or testing therapies in these model. Advanced IT proficiency including electrophysiological and imaging data processing and experience with statistical
-
will allow.) The role will be available for 36 months. About you Successful candidates must have a Postdoctoral qualification (PhD), (or be in the process of submitting a PhD) in Immunology or
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical technology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
on the mechanism(s) and function(s) of mitochondrial segregation in C. elegans using biochemical, molecular, genetic and imaging-based methods, with the goal of advancing our understanding of this process as
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical techn ology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical techn ology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
people with subclinical and clinical disordered eating and related body image concerns and body image management efforts. Appointment at Grade 7 is dependent upon having been awarded a PhD; if this is not
-
biomarker collection and MRI imaging. Both the EJS ACT-PD Trial and Initiative are led by Professor Camille Carroll (Newcastle University, Co-Chief investigator) and Professor Thomas Foltynie (UCL, Co-Chief